Loading...
Publication
I-MOVE-COVID-19: uma rede europeia para investigar, prevenir e controlar a pandemia da COVID-19
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 901.54 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Face à pandemia da COVID-19, a vigilância epidemiológica tem um
papel fundamental para a deteção precoce de casos e a monitorização
da pandemia. A par com a vigilância epidemiológica, importa, também,
investigar fatores protetores e de risco para COVID-19, bem como
estimar a efetividade de intervenções para controlo da doença, desde a
efetividade de intervenções terapêuticas, como a vacina ou de medidas
de saúde pública. Para tal, a rede I-MOVE-COVID-19, composta por 23
parceiros europeus, de entre os quais Portugal, propõe-se a investigar
características epidemiológicas e clínicas de indivíduos com COVID-19,
bem como informações virológicas sobre SARS-CoV-2, através do
estabelecimento de uma plataforma de vigilância adaptável à situação
epidemiológica, de estudos de investigação e da avaliação de intervenções
de saúde pública.
Concerning the SARS-CoV-2 pandemic, epidemiological surveillance plays a key role in the early detection of cases and monitoring of the epidemic. Along with epidemiological surveillance, it is also important to research on protective and risk factors for COVID-19, as well as to estimate the effectiveness of interventions for disease control, from the effectiveness of therapeutic interventions, such as vaccines or public health measures. For this purpose, the I-MOVE-COVID-19 network, composed of 23 European partners, among which, Portugal, proposes to investigate epidemiological and clinical characteristics of individuals with COVID-19, as well as virological information on SARS-CoV-2, through the establishment of a surveillance platform adjustable to the epidemiological situation, research studies and the evaluation of public health interventions.
Concerning the SARS-CoV-2 pandemic, epidemiological surveillance plays a key role in the early detection of cases and monitoring of the epidemic. Along with epidemiological surveillance, it is also important to research on protective and risk factors for COVID-19, as well as to estimate the effectiveness of interventions for disease control, from the effectiveness of therapeutic interventions, such as vaccines or public health measures. For this purpose, the I-MOVE-COVID-19 network, composed of 23 European partners, among which, Portugal, proposes to investigate epidemiological and clinical characteristics of individuals with COVID-19, as well as virological information on SARS-CoV-2, through the establishment of a surveillance platform adjustable to the epidemiological situation, research studies and the evaluation of public health interventions.
Description
Parceiros I-MOVE-COVID-19 (23 parceiros de 15 países europeus):
Public health Institute Albania; Hôpital UZ Brussels, Belgium; Public
Health England; University of Oxford/RCGP RSC, UK; Université
Sorbonne, France; INSERM, France; Institut Pasteur, France; Santé
Publique France; Université de Corse Pascal Paoli, France; Vienna
Vaccine Safety Initiative (ViVI), Germany; HPSC, Ireland; Lithuanian
University of Health Sciences, Lithuania; NIVEL, The Netherlands
RIVM, The Netherlands; INS Ricardo Jorge, Portugal; DGS Portugal;
INCDMIC Cantacuzino, Romania; Public Health Scotland; ISCIII
National Centre for Epidemiology, Spain; ISCIII National Centre for
Microbiology, Spain; ISPL-Navarra, Spain; Public Health Agency,
Sweden; Epiconcept, France.
Keywords
COVID-19 Pandemia da COVID-19 Infeção por SARS-CoV-2 Respostas de Saúde Pública Vigilância Epidemiológica Rede I-MOVE-COVID-19 Estados de Saúde e de Doença Infecções Respiratórias Saúde Pública Europa Portugal
Pedagogical Context
Citation
Boletim Epidemiológico Observações. 2020;9(Supl 12):4-8
Publisher
Instituto Nacional de Saúde Doutor Ricardo Jorge, IP